Kenneth Offit
Kenneth Offit (born February 19, 1955) is an American cancer geneticist and oncologist. He is currently Chief of the Clinical Genetics Service and the Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center. Offit is also a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute, Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College, and a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.
Kenneth Offit | |
|---|---|
| Born | Kenneth Offit February 19, 1955 |
| Nationality | American |
| Alma mater | Princeton University Harvard Medical School Harvard School of Public Health |
| Known for | BRCA2 Research |
| Spouse |
Emily Sonnenblick (m. 1984) |
| Awards | American Society of Clinical Oncology-American Cancer Society Award (2013) |
| Scientific career | |
| Fields | Cancer Genetics, Oncology, Medical Research |
| Institutions | Memorial Sloan Kettering Cancer Center |
Offit has been widely recognized for his discoveries with respect to the genetic bases of breast, colon, and lymphoid cancers. In 2016, he was elected as a Member of the National Academy of Medicine. In 2018, he was named a Fellow of the American Society of Clinical Oncology. In 2021, he was named a fellow of the American Association for the Advancement of Science.